A NOVEL THERAPEUTIC TARGET FOR MITOCHONDRIAL DYSFUNCTION

A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction is a major contributor to a wide range of complex diseases. This deficiency in mitochondrial function can lead to cellular failure, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising treatment for addressing this debilitating issue. EPT Fumarate operates by boo

read more